Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21246384rdf:typepubmed:Citationlld:pubmed
pubmed-article:21246384lifeskim:mentionsumls-concept:C0019196lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C0205466lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C0009429lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C0017431lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C0439230lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C0681890lld:lifeskim
pubmed-article:21246384lifeskim:mentionsumls-concept:C0556895lld:lifeskim
pubmed-article:21246384pubmed:issue4lld:pubmed
pubmed-article:21246384pubmed:dateCreated2011-4-18lld:pubmed
pubmed-article:21246384pubmed:abstractTextTreatment of genotype 1b chronic hepatitis C virus (HCV) infection has been improved by extending peg-interferon plus ribavirin combination therapy to 72 weeks, but predictive factors are needed to identify those patients who are likely to respond to long-term therapy.lld:pubmed
pubmed-article:21246384pubmed:languageenglld:pubmed
pubmed-article:21246384pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246384pubmed:citationSubsetIMlld:pubmed
pubmed-article:21246384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246384pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21246384pubmed:statusMEDLINElld:pubmed
pubmed-article:21246384pubmed:monthAprlld:pubmed
pubmed-article:21246384pubmed:issn1435-5922lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:MoriwakiHisat...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:SakisakaShota...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:ChayamaKazuak...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:KumadaHiromit...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:YoshiokaKenta...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:MatsumotoAkih...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:UenoYoshiyuki...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:NomuraHideyuk...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:OketaniMakoto...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:HiasaYoichiYlld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:YotsuyanagiHi...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:IzumiNamikiNlld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:TakeharaTetsu...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:SeikeMasataka...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:HayesC...lld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:ToyotaJojiJlld:pubmed
pubmed-article:21246384pubmed:authorpubmed-author:OkanoueTakash...lld:pubmed
pubmed-article:21246384pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21246384pubmed:volume46lld:pubmed
pubmed-article:21246384pubmed:ownerNLMlld:pubmed
pubmed-article:21246384pubmed:authorsCompleteYlld:pubmed
pubmed-article:21246384pubmed:pagination545-55lld:pubmed
pubmed-article:21246384pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:meshHeadingpubmed-meshheading:21246384...lld:pubmed
pubmed-article:21246384pubmed:year2011lld:pubmed
pubmed-article:21246384pubmed:articleTitleFactors predictive of sustained virological response following 72 weeks of combination therapy for genotype 1b hepatitis C.lld:pubmed
pubmed-article:21246384pubmed:affiliationDepartment of Medical and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. chayama@hiroshima-u.ac.jplld:pubmed
pubmed-article:21246384pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21246384pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed